First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and ...

Q4 2025 Earnings Call March 19, 2026 4:30 PM EDTCompany ParticipantsDavid Krempa - Chief Business OfficerSean Brynjelsen ...

JAMMU, Mar 13: The Department of Surgical Oncology at All India Institute of Medical Sciences (AIIMS) Jammu has successfully performed a highly complex surgery on a patient with a large left adrenal ...

Net Product Revenue of $5.4 Million for Fourth-Quarter 2025, with >200 Enrollment Forms at the End of December Operationally Seamless Phase 2/3 Study of Atumelnant for the Treatment of ACTH-Dependent ...

Dr. Maluf emphasized that his discussion would focus on penile squamous cell carcinoma and genitourinary basket trials. At ASCO 2024, Dr. Maluf presented the HERCULES (LACOG 0218), a phase II trial of ...

A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how ...

Everyone’s favorite bracket challenge has returned. That’s right—it’s time once again for Fierce Pharma Marketing’s annual ...

In addition to new medications to treat this enzyme deficiency, research is underway on easier hormone sampling and fixing the gene mutation that causes CAH.

Per-protocol survival improved versus earlier cutoffs, with 35% alive beyond 30 months and 13% beyond 50 months after two ...

CAH is a group of genetic disorders that alter hormone production. Learn more about how this condition impacts a woman’s ability to get pregnant.

Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a biological pathway that helps explain why some bladder cancers do not respond well ...

Tirzepatide provided a larger reduction in HbA1c and greater improvements in multiple cardiometabolic parameters compared with conventional care for adults recently diagnosed with type 2 diabetes, ...